JANX

JANX

USD

Janux Therapeutics Inc. Common Stock

$27.010+0.240 (0.897%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$26.770

Haut

$27.660

Bas

$26.330

Volume

1.16M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.6B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.91M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $21.73Actuel $27.010Haut $71.71

Actualités Connexes

Analyst Upgrades

Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics with a Overweight rating and announces Price Target of $47.

Voir plus
Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47
Analyst Upgrades

Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $100.

Voir plus
Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100
Analyst Upgrades

Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Stifel analyst Bradley Canino reinstates Janux Therapeutics with a Buy and announces $45 price target.

Voir plus
Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.